Skip to main content

Site notifications

Guideline on good pharmacovigilance practices (GVP) Module VI – Collection, management and submission of reports of suspected adverse reactions to medicinal products (Rev 2)

We have adopted this International Scientific Guideline - EMA/873138/2011 Rev 2*